InvestorsHub Logo
Followers 26
Posts 1573
Boards Moderated 0
Alias Born 12/03/2009

Re: None

Monday, 04/26/2021 12:03:57 AM

Monday, April 26, 2021 12:03:57 AM

Post# of 124
SUPPLEMENTAL INFORMATION AND DISCLOSURE STATEMENT OF MATERIAL CORPORATE EVENT
FOR IMMEDIATE RELEASE – April 24, 2021
HEALIXA INC
(f/k/a Emerald Organic Products Inc.)
CUSIP: 29101T103
Trading Symbol: EMOR
OTC Pink SupplementalDisclosure
We at Healixa, Inc. (OTC: EMOR, f/k/a Emerald Organic Products Inc.) (“EMOR”) filed a lawsuit on April 20, 2021
against Matthew J. Wanderer and Carie Health, Inc. (f/k/a Carie Health, LLC and Epic Health, LLC (“CHI-E”) and certain
unnamed coconspirators listed as “John Doe Defendant(s)” (collectively the “Defendants”) in the Supreme Court of
the State of New York, County of Suffolk, as a result of a dispute involving a conditional merger agreement entered
into between EMOR and CHI-E on March 30, 2020 which EMOR terminated.
The lawsuit alleges multiple counts of fraud, breach of contract and conversion against the Defendants and seeks a
judicial confirmation that the merger was properly terminated before it closed or, in the alternative, that it should
be deemed a nullity due to procedural irregularities and fraudulent inducements that were revealed in the
continuing due diligence process.
While EMOR plans to vigorously enforce our rights, we cannot predict the outcome of any litigation matter.
Forward-looking Statements
Certain statements contained in this disclosure may constitute forward-looking statements. For example, forwardlooking statements are used when discussing our expected research and development programs, and more. These
forward-looking statements are based only on current expectations of management and are subject to significant
risks and uncertainties that could cause actual results to differ materially from those described in the forwardlooking statements, including but not limited to the risks and uncertainties related to the progress, timing, cost,
and results of Partnerships and product development programs; difficulties or delays in obtaining regulatory
approval or patent protection; and competition from other companies. Except as otherwise required by law,
Healixa Inc., (f/k/a Emerald Organic Products, Inc.), undertakes no obligation to publicly release any revisions to
these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the
occurrence of unanticipated events.
/s/ Ian Parker, Chief Executive Officer
https://backend.otcmarkets.com/otcapi/company/financial-report/279748/content